Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-343,557
Closed -$333K 1900
2025
Q2
$333K Buy
+343,557
New +$285K 0.01% 1332
2025
Q1
Sell
-164,354
Closed -$132K 1499
2024
Q4
$132K Buy
+164,354
New +$150K 0.01% 1087
2024
Q2
Sell
-128,825
Closed -$211K 1767
2024
Q1
$211K Buy
+128,825
New +$108K 0.02% 1132
2023
Q3
Sell
-141,491
Closed -$76.8K 1430
2023
Q2
$76.8K Sell
141,491
-80,300
-36% -$51.5K 0.01% 1147
2023
Q1
$189K Buy
+221,791
New +$242K 0.02% 983
2022
Q4
Sell
-34,037
Closed -$60.6K 1245
2022
Q3
$60.6K Buy
+34,037
New +$84.7K 0.01% 905

Other funds holding OCGN

Y-Intercept (HK)'s OCGN Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Ocugen (OCGN) in Q3 2025, closing a stake of 343,557 shares — an estimated $333K sold.

Y-Intercept (HK) first reported a position in OCGN in Q3 2022 and held it in 6 quarters. The position peaked at $333K in Q2 2025. 97 funds tracked by Wall St. Rank hold OCGN as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Ocugen position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 343,557 Ocugen shares in Q3 2025, an estimated $333K.
  • Y-Intercept (HK) first reported a position in Ocugen in Q3 2022 and held it in 6 quarters.
  • Y-Intercept (HK)'s Ocugen position peaked at $333K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Ocugen as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.